Search Results
Feb 03, 2026, 01:29 ET Why 2026 Marks the Pivot for Real-World Asset Tokenization from Experimental Pilots to Active Global Markets
By synchronizing asset delivery and payment within a single, automated execution framework, platforms are eliminating the manual reconciliation and "T+2" settlement delays that have traditionally hampered private markets."Compliance has evolved from a value-add to a baseline requirement for institutional
More news about: ChainUp
Feb 03, 2026, 01:17 ET Why 2026 Marks the Pivot for Real-World Asset Tokenization from Experimental Pilots to Active Global Markets
By synchronizing asset delivery and payment within a single, automated execution framework, platforms are eliminating the manual reconciliation and "T+2" settlement delays that have traditionally hampered private markets."Compliance has evolved from a value-add to a baseline requirement for institutional
More news about: ChainUp
Feb 03, 2026, 00:27 ET Herbal Oasis de cbdMD se expande a Luisiana con Morales Beverage Group después de su fuerte impulso en Texas
vida premium en toda Luisiana."Luisiana representa otro peldaño importante para nosotros y para la expansión de la marca Oasis de cbdMD", afirmó T. Ronan Kennedy, director general de cbdMD. "La alianza con MBG nos da el alcance y magnitud necesarios para llevar a Oasis a los minoristas de todo el
More news about: cbdMD, Inc.
Feb 02, 2026, 22:08 ET WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager
announced that it has signed a license and research service agreement with Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) for an innovative trispecific T-cell Engager (TCE) for the treatment of B-cell mediated autoimmune diseases. Under the agreement, Vertex will have exclusive global rights to develop
More news about: WuXi Biologics
Feb 02, 2026, 20:00 ET Total Investment of Approx. USD 8.8 Million in Malaria, Tuberculosis, and NTD R&D Projects with Partners Including Mahidol University, Barcelona Institute for Global Health, and Eisai
and market authorization of the T. cruzi-LAMP diagnostic prototype in Argentina and Bolivia. The newly generated results will play a key role to respond the regulatory agencies requests, which include the analytical validation work conducted within the T. cruzi-LAMP verification studies
More news about: GHIT Fund
Feb 02, 2026, 20:00 ET Total Investment of Approx. USD 8.8 Million in Malaria, Tuberculosis, and NTD R&D Projects with Partners Including Mahidol University, Barcelona Institute for Global Health, and Eisai
and market authorization of the T. cruzi-LAMP diagnostic prototype in Argentina and Bolivia. The newly generated results will play a key role to respond the regulatory agencies requests, which include the analytical validation work conducted within the T. cruzi-LAMP verification studies
More news about: GHIT Fund
Feb 02, 2026, 18:45 ET Elliott Management Statement on Toyota Industries Corporation
L.P.Investor Contacts:Okapi Partners LLCNew York: Pat McHughT:+1 212 297 0720Toll Free: (877) 629-6357London: Christian JacquesT: +44 20 3031 [email protected]
More news about: Elliott Investment Management L.P.
Feb 02, 2026, 18:25 ET /C O R R E C T I O N -- Monetary Metals & Co./
More news about: Monetary Metals & Co.
Feb 02, 2026, 17:31 ET TIGIT Inhibitors Market Poised for Strong Growth Through 2034, Driven by Expanding Immuno-Oncology Pipeline | DelveInsight
concurrently blocking PD-1 interactions with PD-L1/PD-L2 and TIGIT interactions with CD112/CD155, it reinvigorates T-cell activity and boosts CD226-mediated signaling in NK cells and CD8⁺ T cells, thereby strengthening anti-tumor immune responses. Rilvegostomig is under clinical evaluation in non-small
More news about: DelveInsight Business Research, LLP
Feb 02, 2026, 17:02 ET 78 Greenberg Traurig Lawyers Named to Thomson Reuters Stand-out Lawyers List
Paul T. FoxLitigation
More news about: Greenberg Traurig, LLP
Feb 02, 2026, 16:00 ET CREATE Medicines Demonstrates Complete B Cell Depletion and Repeatable Dosing in Non-human Primates with In Vivo CAR-T Platform
therapies, demonstrating that targeted T cell programming is not only possible, but redosable and clinically de-risked with our platform."Key Highlights:Complete B cell depletion in NHPs using both a next-generation T cell receptor-specific CAR and a conventional
More news about: CREATE Medicines, Inc.
Feb 02, 2026, 15:29 ET Monster Energy's Justin Gaethje Defeats Paddy Pimblett to Claim UFC Interim Lightweight Championship Title at UFC 324
UFC 324: Gaethje vs. Pimblett was contested in front of a live crowd of 19,481 spectators inside sold-out T-Mobile Arena in Las Vegas. Featuring Gaethje in the UFC World Championship fight and a total of five bouts on the Main Card, the spectacle was broadcast
More news about: Monster Energy
Feb 02, 2026, 15:02 ET Jeffrey A. Flaks recognized as Press Ganey's HX26 Innovator of the Year
compassion and collaboration, the impact reaches far beyond our doors — into homes, neighborhoods, and lives across Connecticut and beyond."Patrick T. Ryan, Chairman and CEO of Press Ganey, added, "Jeff Flaks treats innovation as a responsibility to move healthcare forward. He is relentless in pushing
More news about: Hartford HealthCare
Feb 02, 2026, 14:41 ET Piramal Pharma Solutions presenta capacidades de comprimido en cápsula
https://mma.prnewswire.com/media/2874816/Piramal_Pharma_Solutions_AF_90T_Encapsulator.jpgFoto -
More news about: Piramal Pharma Solutions
Feb 02, 2026, 13:37 ET AT&T, ActiveProtective and JACS Collaborate to Enhance Senior Safety with New Tango Belt Connectivity Device
our customers exceed expectations," said Lee Wagner, AVP of Connected Solutions at AT&T. "By fostering strong relationships with experts in this field and maintaining a commitment to reliability and security, AT&T connectivity enhances patient care through innovative connected solutions."AT&T's
More news about: JACS Solutions
Feb 02, 2026, 13:10 ET Piramal Pharma Solutions stellt seine Fähigkeiten im Bereich Tablette-in-Kapsel vor
https://mma.prnewswire.com/media/2874816/Piramal_Pharma_Solutions_AF_90T_Encapsulator.jpgFoto -
More news about: Piramal Pharma Solutions
Feb 02, 2026, 12:53 ET Discount Tire Recognized in Glassdoor's Best Places to Work 2026
more.About Discount TireDiscount Tire is a leading independent retailer of tires, wheels, and windshield wipers. Founded in 1960 by Bruce T. Halle, the company serves customers at more than 1,250 stores in 40 states. The company does business as Discount Tire in most of the U.S. and as America's
More news about: Discount Tire
Feb 02, 2026, 12:53 ET Neumático con descuento reconocido en los mejores lugares para trabajar de Glassdoor 2026
de Discount Tire Discount Tire es un minorista independiente líder de neumáticos, ruedas y limpiaparabrisas. Fundada en 1960 por Bruce T. Halle, la compañía atiende a clientes en más de 1.250 tiendas en 40 estados. La compañía opera como Discount Tire en la mayor parte de los EE. UU. y
More news about: Discount Tire
Feb 02, 2026, 11:07 ET Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities
https://mma.prnewswire.com/media/2874816/Piramal_Pharma_Solutions_AF_90T_Encapsulator.jpgPhoto -
More news about: Piramal Pharma Solutions
Feb 02, 2026, 11:00 ET Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities
https://mma.prnewswire.com/media/2874816/Piramal_Pharma_Solutions_AF_90T_Encapsulator.jpgPhoto -
More news about: Piramal Pharma Solutions
Feb 02, 2026, 11:00 ET Kroger Reveals Top Party Picks and Savings for the Big Game
cream and sprinkles.Score big savings with Kroger's hot features, BOGOs and weekly digital deals, including*:T-bone steaks for just $9.99 per poundWhole Boneless Beef Brisket as low as $2.99 per poundBig Game BOGOs: Pork Back Ribs, Oscar Mayer
More news about: The Kroger Co.